Park Ha Biological Technology Co annual free cash flow
2022
2023
2024
2025
Park Ha Biological Technology Co reported −$2,973 in free cash flow for fiscal 2025, a decrease of $877,874 from the previous fiscal year, with a free cash flow margin of −0.12%.
View full Park Ha Biological Technology Co company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-10-31 | −$2,973 | −$877,874 | — | −0.12% |
| 2024 | 2024-10-31 | $874,901 | $771,040 | +742.38% | +36.73% |
| 2023 | 2023-10-31 | $103,861 | −$1.3M | −92.74% | +4.22% |
| 2022 | 2022-10-31 | $1.4M | — | — | +74.52% |
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Park Ha Biological Technology Co source filings ↗